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Abstract
The disparity between survival rates for Black and White women with breast cancer is
well documented and has been examined in terms socioeconomics, environment, tumor
type, and genetics. However, there is little examination of the role of health care
facilities in cancer disparities. Health care facilities are representative of societal norms
and beliefs that include location, quality of care, finance, policies, and staffing; therefore,
they are a proxy for social justice and social change. The purpose of this study was to
examine correlations between health care facility type; social determinants of cancer such
as poverty, culture, and social justice; and breast cancer survival rates. Using the social
determinants of cancer theoretical framework, the breast cancer survival rate of 4,087
Black and White women in Georgia between the ages of 45 and 69 was studied. The
relationship between breast cancer survival and predictors including race, income, health
care facility type, grade, and tumor type (4 sub-variables) were examined using the
Kaplan-Meier Method, log-rank test, and Cox proportional hazard model. The log-rank
test suggested no statistically significant difference in the survival functions among
patients in different health care facilities (χ2(2) = 0.0150, p = 0.9926). The Cox
proportional hazard model suggested no statistically significant relationship between
breast cancer survival and health care facility type, after controlling for other predictors
(χ2(2) = 0.3647, p = 0.8333). This result indicates that healthcare facilities do not
influence breast cancer survival rates, however given the persistent health outcome
disparities further research in the area is warranted.
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Chapter 1: Introduction to the Study
Of all the forms of inequality, injustice in health is the most shocking
and the most inhuman because it often results in physical death
—Martin Luther King, Jr., 1966
In 2014, the Center for Reproductive Rights cited accounts of discrimination in
the health care system, leading to adverse health outcomes. However, when surveyed,
most physicians have responded that their personal biases do not affect their ability to
respond and treat patients of diverse backgrounds (Blair et al., 2014). Despite these
responses, data has indicated that physician bias is inversely related to quality of
decisions regarding treatment and communication with Black patients, especially
regarding diseases associated with minority patient groups (Moskowitz, Stone, & Childs,
2012).
Although the incidence rate in Georgia for female breast cancer for Black women
is lower than White women, the estimated 5-year survival probability for White women is
0.8648 compared to 0.7833 for Black women. The difference in mortality rates is a
significant health disparity (Hunt et al., 2013); however, it can be studied using the social
determinants framework of Freeman and Chu (2005). Three primary social
determinants—poverty, culture, and social justice—influence early detection, diagnosis,
treatment, posttreatment quality, and survival mortality of cancer. Poverty leads to a lack
of resources and information in addition to inadequate living conditions and risky
behaviors, culture shapes people’s environments and perceptions and actions of their
environments, and social justice dictates principles of equity and justice. Thus, these
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three factors were investigated because they may influence disparities in breast cancer
survival rates between Black and White women in Georgia.
In this study, income was used as a proxy for poverty, race was a proxy for
culture, and the hospital demographic of control/ownership type was the proxy for social
justice. Data were collected from the Georgia Center for Cancer Statistics, which is the
Surveillance, Epidemiology, and End Results database for the state of Georgia, and the
American Hospital Association. Chapter 2 contains a review of the literature surrounding
this topic. The methods used to answer the research questions are outlined in Chapter 3.
Background
Researchers have suggested that since the establishment of the U.S. health care
system in the 19th century, there have been conscious efforts to structure the system to be
racially and socially separate (Feagin & Bennefield, 2014; Krieger, 2014; White, Haas, &
Williams, 2012; Williams & Mohammed, 2013). For example, prior to 1960, there was
an institutional mandate that Blacks and Whites should receive care on separate floors
(White et al., 2012). The 1964 Civil Rights Act, Title IV was designed to end the
practice of separate and unequal health care systems through the mandate of equal access
for all races (Yearby, 2014). But the remnants of institutionalized discrimination remain
from decades of structural racism (Feagin & Bennefield, 2014; Krieger, 2014; Molina,
Silva, & Rauscher, 2015; Viruell-Fuentes, Miranda, & Abdulrahim, 2012). Despite legal
assurances, the health care system has institutionalized policies that result in racial
disparities due to unequal access for Blacks compared to Whites, resulting in racial
disparities in health care. For example, the ability of the American Medical Association
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to control the market supply of physicians through profit maximization (Friedman, 1962;
Kessel, 1958) or quality control among physicians (Arrow, 1963; Leffler, 1978) has been
noted since the late 1950s. These regressive policies have led to medically underserved
areas, and racial inequalities have endured because of race-based socioeconomic
differences (Phelan & Link, 1995).
Overall, the health status of Americans has improved in recent years; however,
racial inequities in the United States continue to persist (Akinboro et al., 2015; Anderson,
2012; Chen & Li, 2015; Molina et al., 2015). Racial inequity in the health care system
violates principles of social justice (Rivera, 2014; Roux, 2012; Smedley & Myers, 2014)
in addition to increasing the United State’s economic burden. The United States
currently spends $2.7 trillion on health care costs, which is an estimated 18% of U.S.
gross domestic product (Moses et al., 2013). Annually, the United States loses $200
billion due to premature deaths related to racial health care disparities (Ayanian, 2015).
The elimination of racial inequities in the health care system is one of the four key
goals of Healthy People 2020 (U.S. Department of Health and Human Services, 2012).
Recommendations and strategies to address racial inequities have been focused on the
promotion of awareness of disparities in the public and medical sector (U.S. Department
of Health and Human Services, 2012). Despite the emphasis on awareness, the United
States has been unable to eradicate racial inequalities in the health care system. The 2014
Agency for Healthcare Research and Quality, National Healthcare Quality and
Disparities Report found that as of 2012, disparities in quality of care not only failed to
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decrease but certain disparities, such as breast cancer among Black women, increased
(U.S. Department of Health & Human Services, 2015).
To address racial inequalities in health care, it is important to understand how
systems are structured within the context of norms and policies. The socioeconomic
status paradigm has in many ways placed the burden to fix the system on those who have
been disenfranchised by the health care system. Bronfenbrenner (1977) recognized in the
model of social ecology that the relationship between individuals and their environmental
system are interdependent. Individuals do not typically act outside of their environment’s
system and system constraints, and reciprocally, individuals are a reflection of the
individuals that comprise the system. In this context, the different levels and components
(structures and institutions) of the system are a proxy for individual beliefs and norms.
Previous studies have established that racism occurs on several levels of society
(Feagin & Bennefield, 2014; Jones, 2002; Matthew, 2015). Jones (2002) defined racism
as
A system of structuring opportunity and assigning value based on the social
interpretation of how we look that unfairly disadvantages other individuals and
communities and unfairly advantages other individuals and communities, and saps
the strength of the whole society through the waste of human resource. (p. 9)
Jones’s system-based definition of institutionalized racism is derived from the structures
of a system such as policies and norms that sometimes prevent access based on race. In
contrast to institutionalized racism, structural racism is defined at system macro levels.
Structural racism has been defined as racism that influences socioecological levels and
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does not require the involvement or intent of individuals (Bonilla-Silva, 1997); it is selfsustaining (Link & Phelan, 1995), and if individual and interpersonal discrimination were
eliminated, the racial inequities resulting from structural racism would remain due to its
self-sustaining nature (Jones, 2002). Consequently, interventions that target individual
awareness will have minimal impact on racial inequities resulting from structural racism.
Therefore, there needs to be a paradigm shift from an examination of individuals to an
examination of the health care system in terms of delivery and quality of care to address
racial inequalities (Baron et al., 2014; Feagin & Bennefield, 2014; Jones, 2002; Wheeler,
Reeder-Hayes, & Carey, 2013).
Several studies since 2010 have addressed the awareness of racial inequities in the
medical community with the purpose of assessing individual belief paradigms (Greysen
et al., 2011; Haider et al., 2015; Medina-Walpole, Mooney, Lyness, Lambert, & Lurie,
2012; Paradies, Troung, & Priest, 2014; People, 2013; Roux, 2012; Williams &
Mohammed, 2013). However, there is a need for research on the relationships between
system-level issues and their impact on addressing timeliness in detection (Molina et al.,
2015); the impact of multisystem, multifactorial approaches (Chen & Li, 2015); and the
influence of institutionalized policy on the distribution of and access to health resources
(Smedley & Myers, 2014).
Addressing issues with the health care system is especially important to examine
the disparities in mortality rates between Black and White women. For example, the
disparate breast cancer mortality outcomes for Black women have been well documented
(Chen & Li, 2015; Molina et al., 2015; Tatalovich et al., 2015). Studies on the
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relationship between social determinants and disparate breast cancer mortality outcomes
for Black women suggest that economic and social barriers are related to Black women
breast cancer outcomes (Januszewski, Tanna, & Stebbing, 2014; Reeder-Hayes, Wheeler,
& Mayer, 2015; Wheeler et al., 2013). The difference in mortality rates is notable
because White women are more frequently diagnosed with breast cancer (Siegal, Miller,
& Jamal, 2015). Despite research and interventions in addressing these differences in
mortality rates, it remains an issue. Researchers need to examine outcomes determined
by interactions within the health system, particularly the points of service represented by
health care facilities, because of the disparity between treatments and outcomes
(Carpenter et al., 2011; Wheeler et al., 2012a, 2012b, 2013).
Problem Statement
Breast cancer is currently the most common form of cancer diagnosed among
women in the United States, with 1 in 3 cancers attributable to breast cancer (DeSantis,
Ma, Bryan, & Jemal, 2014). The estimated 2013 incidence was 296,980 new cases of
breast cancer and 39,620 related deaths (DeSantis et al., 2014). The incidence rate from
2006–2010 of female breast cancer per 100,000 women in Georgia was 124.0 for White
women and 120.9 for Black women (DeSantis et al., 2014). However, during the same
period, the death rate per 100,000 of White females was 21.9, while the death rate of
Black females was 29.6 (DeSantis et al., 2014). Although the incidence rate for female
breast cancer for Black women is lower than White women, the estimated 5-year survival
probability for White woman is 0.8648 compared to 0.7833 for Black women (DeSantis
et al., 2014).
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It was not until the early 1970s that surveillance of breast cancer was
institutionalized (Yamauchi et al., 2012), which brought more awareness to the
differences in breast cancer rates based on race. For instance, White, Daling, Norsted,
and Chu (1987) conducted a study that revealed a higher incidence of breast cancer in
Black women (as cited in Krieger, 1988), though their concern was with an increased
incidence of breast cancer in women’s decision to delay childbearing. In recent years, the
reason for the higher mortality rate of Black women has been examined to determine
cause (Hunt et al., 2013). For example, Chen and Li (2015) examined treatment
variations based on type of breast cancer and found that certain racial and ethnic groups
were behind Whites in receiving early diagnosis and recommended treatments. Racial
disparities in breast cancer mortality may exist due to Black women’s lower access to
preventive screenings and treatment and lower quality care due to issues like comorbid
diseases, provider–patient miscommunication, and mistrust (Hunt et al., 2013).
Additionally, there might be a link between the health care facility and social
determinants such as median household income, racial segregation, and financial
inequality that leads to discontinuity in breast care evaluation and treatment (Daly &
Olopade, 2015; Hunt et al., 2013). Regardless of why, the racial disparity in care affects
health outcomes and survival rates (Daly & Olopade, 2015).
Though there is attention on genetic solutions to the disparity in breast cancer
mortality, equal access to quality early detection and treatment can address the racial
disparities in mortality rates (Hunt et al., 2013). Higher rates of late stage breast cancer
are more probable in areas with predominant Black populations where screening
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availability is low (Tatalovich et al., 2015). In addition, previous research has been
focused on patient-level factors but less is known about what role health care facilities
play in breast cancer care (Molina et al., 2015). Therefore, this study was conducted to
address the problem of racially disparate mortality rates and determine how type of health
care facility and social determinants such as median household income, racial
segregation, and financial inequality affect breast cancer care.
Purpose Statement
The purpose of this quantitative study was to determine if the social determinants
of poverty, culture, and social justice factors outlined in the health inequalities framework
correlate to the breast cancer survival rate of Black and White women in Georgia. Data
were collected from the Surveillance, Epidemiology, End Results national cancer
database, the Georgia Center for Cancer Statistics, and the American Hospital
Association. The data were analyzed using Kaplan Meir method, log-rank tests, and Cox
proportional hazards model (see Kleinbaum & Klein, 2012) to examine the relationship
between the breast cancer survival rate of Black and White women in Georgia and the
predictors of race, income, health care facility type, grade, and tumor type.
Research Questions
The following research question was designed to guide this study: Do poverty,
culture, and social justice affect the breast cancer survival rate of Black and White
women in Georgia? The following are research questions and hypotheses based on
answering this central question:
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Research Question 1: Is poverty (income) a determinant of the breast cancer
survival rate of Black and White women in Georgia?
H01: Poverty is not a determinant of the breast cancer survival rate of Black
and White women in Georgia.
Ha1: Poverty is a determinant of the breast cancer survival rate of Black and
White women in Georgia.
Research Question 2: Is culture (race) a determinant of the breast cancer survival
rate of Black and White women in Georgia?
H02: Culture is not a determinant of the breast cancer survival rate of Black
and White women in Georgia.
Ha2: Culture is a determinant of the breast cancer survival rate of Black and
White women in Georgia.
Research Question 3: Is social justice (type of health care facility) a determinant
of the breast cancer survival rate of Black and White women in Georgia?
H03: Social justice is not a determinant of the breast cancer survival rate of
Black and White women in Georgia.
Ha3: Social justice is a determinant of the breast cancer survival rate of Black
and White women in Georgia.
Research Question 4: What is the relationship between poverty, culture, and
social justice as a determinant of the breast cancer survival rate of Black and
White women in Georgia?
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H04: None of the independent variables (poverty, culture, and social justice)
have a statistically significant relationship on breast cancer survival rates of
Black and White women in Georgia.
Ha4: The independent variables (poverty, culture, and social justice) have a
statistically significant relationship on breast cancer survival rates of Black
and White women in Georgia.
Theoretical Framework
The theoretical framework for the study was the social determinants of health
inequalities framework as outlined by Marmot (2005). However, the cancer-related
social determinants framework as described by Freeman and Chu (2005) was also
applied. In general, the social determinants of health correlate disease to social settings.
In the context of cancer outcomes, the social determinants of poverty, culture, and social
justice influence early detection, diagnosis, treatment, posttreatment quality, and survival
rates. For example, poverty leads to a lack of resources and information (Freeman &
Chu, 2005). In the study, income was a proxy for poverty. In addition, culture, which
can be defined as behavior that has been developed and passed on through generations
(Mead, 1963) as well as the knowledge and behavior shared by a group (Peoples & Baily,
2012), was determined in this study by race. Finally, social justice can be defined as a
point in time when societal power allows for the distribution of outcomes that does not
result in an exploiter or victim (Walster et al., 1975). In this study, the type of a health
care facility was the proxy for social justice. These three factors were investigated
regarding disparities in breast cancer survival rates between Black and White women.
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There is a need to address established health disparities through health inequities
rooted in social issues (culture), poverty (economics), and the direct effect of structural
racism (social justice; Rice, Nadig, Simpson, Ford, & Goodwin, 2014). It is through
these mechanisms that health inequities exist. However, several studies on racial
discrimination in health care include the perspective that Blacks’ genetic predisposition
(Dietze, Sistrunk, Miranda-Carboni, O’Regan, & Seewaldt, 2015), personal choices
(Slattery et al., 2014), or personal responsibility (Geers et al., 2013; Newson et al., 2013;
Voigt, 2013) results in a higher disease rate than Whites. Key examples of these
perspectives can be found in breast cancer research (Anderson, Mackison, Boath, &
Steele, 2013; Paxton, Taylor, Chang, Courneya, & Jones, 2013; Weber, Solomon, &
Meyer, 2013). This assumes the concept of risk and does not examine the role of
structural or institutionalized discrimination in increasing the disease incidence or
mortality rate. Therefore, this study was conducted to examine how poverty (income),
culture (race), and social justice (type of health care facility) affect cancer rates among
White and Black women.
Nature of Study
My study is quantitative and involved a retrospective cohort design to study
similarly situated groups that differ by a specific characteristic (see Downing et al.,
2014). Using a retrospective cohort design, I examined common exposure factors such as
health care facility type, income, and race to determine their influence on survival
outcomes between Black and White women. This study design is consistent with the
collection and analysis of numerical data collection based on mathematical methods to
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prove or disprove a hypothesis (see Creswell, 2013). The traditional realist worldview
advocates that the quantitative approach is used to uncover truth using objective research
and methods of analysis (Creswell, 2013). This approach allowed for the objective
examination of the controversial issues of race and health
Definitions
Health care facility: The study includes three ways of defining health care
facilities:
•

For-profit: Health care facilities that are not barred from distributing profits,
typically privately owned

•

Nonprofit: Health care facilities barred from distributing profits

•

Government: Health care facility owned by a government entity (Bjorvatn,
2018).

Poverty: The official definition of poverty is based on economic guidelines
established by the U.S. Department of Health & Human Services. For example, a family
of three with a total income of $20,160 is considered to be living in poverty (Federal
Register, 2016).
Social justice: There are two commonly accepted definitions of social justice.
Rawls (2009) advocated that in an environment of scare resources and competing
interests, people will choose to advance those interests on mutually acceptable terms and
if people are kept ignorant regarding their position, then principles of justice will be
chosen that are fair to all. This definition is sometimes referred to as noncomparative
social justice. In contrast, Miller (1979) suggested a more pluralist approach: justice is
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given through the considered relationship between the people involved. This perspective
is often referred to as comparative social justice. It is this definition that Freeman and
Chu (2005) adopted in the social determinants framework to address inequities in health
care delivery and access particularly related to cancer, which was used in this study.
Assumptions, Limitations, and Delimitation
The study assumed that the data from the Georgia Cancer Registry and the
American Hospital Association would provide definitive, up-to-date information to
answer the research questions.
The limitations for the study are that the data used to analyze the research
questions were collected from the Georgia Cancer Registry, which only collects data for
one state. Therefore, the findings cannot be generalized nationally. Additionally, the
quantitative results of the study can only demonstrate correlation and not causation.
Finally, a delimitation of this study was the breadth. The study was limited to
health care facilities in Georgia and Black and White women in Georgia diagnosed with
breast cancer. Data were downloaded from the Georgia Cancer Registry and the
American Hospital Association. This study was only conducted to determine if there is a
correlation between the three social determinants of poverty, culture, and social justice.
No causal nature of any identified relationship would be able to be determined, though
the study provides preliminary data that can serve as a foundation for further research that
can elucidate causal relationships.
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Significance
It is well documented that disparities exist for Black women regarding the
prevention, diagnosis, and treatment of breast cancer (Chen & Li, 2015). If accessing a
type of health care facility is positively or negatively associated with survival rates, the
information derived from the study may provide information to patients and providers to
make an educated choice regarding prevention and treatment. Findings from the study
may also help health care facilities improve the way they work with patients, which can
lead to improved health outcomes.
Social Change
Scientific pursuit sometimes needs to involve pieces of knowledge rather than
cumulative knowledge (Kuhn, 2012), which represents this study’s purpose of providing
knowledge on disparities in mortality rates between White and Black women. In my
study, I examined the effect of health care facilities on health outcomes, going beyond the
variables of race, gender, and income that are commonly investigated. My approach
addresses the core of public health policy—social justice. Social justice demands that
public health address disparities based on health inequities to eliminate health disparities.
Rather than claiming that Black women have higher mortality rates from breast cancer
because they are Black and may have a lower socioeconomic status, “The causes of the
causes” (p. 1101) need to be addressed (Marmot, 2005, p. 1101). Examining the
institutions through which Black women receive preventative care, screening, diagnosis,
and treatment is central to understanding how being Black with lower socioeconomic
status influences their care in the current health care system.
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Health care facilities are representative of societal norms and beliefs that include
location, quality of care, finance, policies, and staffing; therefore, they can be used as a
proxy for social justice. In this study, I sought to understand the role of health care
facilities in disparate health outcomes. As illustrated by Frieden’s (2010) health impact
pyramid, addressing structural issues of socioeconomic disparities through policy will
lead to lasting societal changes resulting in improved health outcomes. Therefore, this
study may lead to social change through findings highlighting the effect of health care
facilities on breast cancer mortality rates between Black and White women.
Summary
Although the incidence rate in Georgia for female breast cancer for Black women
is lower than White women, the estimated 5-year survival probability for White women is
0.8648 compared to 0.7833 for Black women. Thus, the difference in mortality rates is a
significant health disparity (Hunt et al., 2013). In this study, this health disparity was
studied using the social determinants framework of Freeman and Chu (2005) with three
primary social determinants: poverty, culture, and social justice, which can affect early
detection, diagnosis, treatment, posttreatment quality, and survival mortality of cancer.
Poverty leads to a lack of resources and information, resulting in inadequate living
conditions and risky behaviors. Shared culture and the consequent transfer of knowledge
and customs can further enhance or diminish the influence of poverty. Finally, social
justice is reflected in the resources brought to the community through the health care
facility. Thus, these three factors that can influence disparities in breast cancer survival
rates between Black and White women in Georgia were investigated. In the study,
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income was used as a proxy for poverty, race was a proxy for culture, and type of health
care facility was the proxy for social justice. Data were collected from the Georgia
Center for Cancer Statistics and the American Hospital Association. Chapter 2 contains a
review of the literature surrounding this topic.
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Chapter 2: Literature Review
The function of this literature review is to provide an overview of the literature
pertaining to health care facilities as a predictor of breast cancer mortality rates. The
literature review includes the theoretical foundation for the study and a review and
synthesis of literature relevant to key concepts of the study. Currently breast cancer is the
most common form of cancer for women in the United States (DeSantis et al., 2014). In
Georgia, the 2013 incidence rate for female breast cancer per 100,000 women was 124.00
for White women and 120.4 for Black women, yet the mortality rate (per 100,000) during
the same period for White women was 21.9 and 29.6 for Black women (DeSantis et al.,
2014). This health disparity is significant (Hunt et al., 2013) and has been confirmed in
peer-reviewed literature, though studies have been limited to the socioeconomics of the
affected women. Although studies mention institutional factors, no studies were found
that identified specific institutional causes.
Literature Search Strategy
PubMed (inclusive of Medline and CINHAL) was used online to locate peerreviewed literature. The following search terms were used: African American women,
Black women, breast cancer, health care facilities, mammogram, access to health care,
socioeconomic status, survival, screening, neighborhood, access, hospital ownership
type, and breast cancer. The initial keyword searches resulted in 1,286 records.
Abstracts were scanned and duplicates were removed resulting in 987 articles.
Backward and forward snowballing was conducted to identify new papers not included in
the original set. This process was continued until no new relevant papers could be found.
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Papers were reviewed for either exclusion or inclusion. The full text review for relevance
resulted in a total of 987 articles. A total of 138 articles were included in the study.
Theoretical Foundation
In this study, I applied the social determinants of health and the determinants of
cancer disparities (see Freeman & Chu, 2005). Whereas the social determinants of health
delineate factors that affect health (World Health Organization, 2016), the social
determinants of health inequalities involve social factors that lead to health inequalities
(Marmot, 2005). These determinants include conditions in which people live and work,
and include economic stability, availability of health care, social and community context,
and education (U.S. Department of Health and Human Services, 2012). The social
determinants of health inequalities include the triad of health systems, poverty/inequality,
and social determinants (Marmot, 2005). The underlying premise is that poverty and
inequality in all its forms can be material in its impact on health outcomes. Health
system and social determinant interventions that do not address material resources
(poverty) and who receives the resources (inequality) will fail to address the causes of the
causes of health disparities (Marmot, 2005).
Freeman and Chu (2005) further refined the determinants of health inequalities
with their focus on the social determinants of cancer disparities. They suggested that
there is a lack of relationship between the medical advances (discoveries) made in cancer
and the delivery (inequality), leading to a disparity in the health outcomes of cancer
(Freeman & Chu, 2005). Freeman and Chu presented a three-pronged approach to
understanding this lack of relationship: culture, poverty, and social injustice. Poverty can
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manifest as a “lack of resources, inadequate information and knowledge, substandard
living conditions, risk-promoting lifestyles, attitudes, behaviors, diminished access to
health care, and poor nutrition” (Freeman & Chu, 2005, p. 656). Culture includes “an
individual’s or community’s shared communication system, similarities in physical and
social environments, common beliefs, values, traditions, and world view, and similarities
in lifestyle, attitude, perceptions, and behavior” (Freeman & Chu, 2005, p. 656). Finally,
social justice consists of racial discrimination that limits equal access to health care for
some populations (Freeman & Chu, 2005, p. 656). It is through this perspective
regarding these determinants that I viewed the impact of social determinants on
prevention, screening, diagnosis, treatment, and rehabilitation regarding cancer.
Though science and medicine use race as a proxy for culture, poverty,
socioeconomics, and behaviors, race within Freeman and Chu’s (2005) paradigm
becomes a separate social construct. Freeman and Chu proposed that there a meaningful
difference between culture and race. Race as a social construct has no scientific or
medical meaning, but rather a means developed by the Office of Management of the
Budget to monitor and enforce civil rights laws. Freeman and Chu stated that racial
categories represent a way to collect data on race and ethnicity for populations but are not
anthropologically or scientifically based (p. 664). In medicine, race has been
demonstrated to lead to disparate prevention, treatment, distribution of care, and false
provider assumptions resulting in racial profiling (Nelson, 2002; Silber et al., 2013).
Thus, Freeman and Chu provide an approach to understanding social determinants that go
beyond race.
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Similar to Freeman and Chu (2005), in this study, I sought to move beyond race
as a proxy for understanding racial disparities in mortality rates among Black women
with breast cancer. This has been supported in other research; for example, Zonderman
et al. (2014) used the Freeman and Chu concept of social determinants of cancer
disparities as a premise to develop a genetics-based framework that employed poverty
rather than race as a premise. By doing so, Zonderman et al. recognized that poverty
results in conditions correlated with health disparities more often than race. Furthermore,
a study conducted by Roman et al. (2014) showed an expanded understanding of poverty,
culture, and social justice. Although Roman et al. used concepts of race to categorize
their results, their findings of health literacy and physician recommendations cut across
race. Additionally, Gerand and Pai (2008) explicated the Freeman and Chu conceptual
framework by describing specific barriers related to poverty, culture, and social justice:
lack of primary care, geographical, physical access to care, comorbidities, health
insurance, system level factors such as screening services, medical mistrust, and racism.
This supports Freeman and Chu’s premise that barriers are related to poverty, culture, and
social justice.
With the guidance of Freeman and Chu’s (2005) framework, I examined
associations between characteristics of health care facilities and the survival rates of
Black women and White women. Health care facilities are institutions that provide
health care services to patients. An institution is an entity with an accepted system of
practices that creates shared constructs and confers a hierarchy so that those at a higher
status can perform functions than those at a lower status, thought there is collective
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intentionality (Searle, 2005). As early as 1972, medicine was recognized as a social
institution that makes collective judgements in the name of health. Ownership or control
of hospital services is a proxy of institutionalized medicine, as a social institution in the
health care system embodies the institutionalized practices, policies, and procedures of
institutionalized medicine (Bjorvatn, 2018, Eskoz & Peddecord, 1985; Sloan et al., 2001).
Though racial constructs are often used in medicine and science to describe the social
phenomenon of poverty, culture, and social justice, the Freeman and Chu conceptual
framework allows for defining more precise variables that can affect the cancer
continuum.
Disparate Breast Cancer Outcomes
Despite advances in medical research, interventions, and outreach, disparities in
breast cancer mortality rates continue to exist among Black and White women in the
United States (Veluswamy, Kinberg, & Bickell, 2013). As of 2015, 231,840 new cases
of breast cancer were diagnosed, and it is estimated that 40,290 deaths will result from
these new cases (DeSantis et al., 2016). Additionally, (a) breast cancer incidence rates
increased for Black women, and (b) the mortality rate gap increased between Black and
White women (DeSantis et al., 2016). As of 2013 breast cancer incidence rate for Black
women was less than for White women, but the mortality rate for Black women rose to
42% while the mortality rate for White women remained flat compared to previous years
(DeSantis et al., 2016). In Georgia, the incidence ratio between Black and White women
was .99 or no meaningful difference in incidence rates of breast cancer between Black
and White women. However, the mortality rate for White women in Georgia between
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2008 and 2012 was 21.2 per 100,000 women (DeSantis et al., 2016). The mortality rate
for Black women in Georgia between 2008 and 2012 was 29.5 per 100,000 women
(DeSantis et al., 2016). Black women in Georgia were almost 40% times more likely to
die from breast cancer than White women in Georgia.
Tumor Type
For over ten years, it has been a part of routine care to test for markers of breast
cancer (Anderson, Rosenberg, & Katki, 2014), yet racial disparities in breast cancer
continue to exist (DeSantis et al., 2016; Wheeler et al., 2013). Black women in the
United States comprise the most significant proportion of women diagnosed with HR/HER2- (triple negative) breast cancer, whereas White women in the United States
comprise the most significant proportion of women diagnosed with the most responsive
form of breast cancer, HR+/HER2- (DeSantis et al., 2016).
Although there are 21 histologic types of breast cancer, only four are molecular
types of breast cancer (DeSantis et al., 2016). The molecular types are based on the
expression of two receptors: the hormone receptor and the human growth factor-neu
receptor (HER2; Howlader et al., 2014; Kohler et al., 2015). Breast cancer type
HR+/HER2+ has proteins that promote cancer cells and can be treated with hormone
therapies. However, Type HR+/HER2- is the most common. It can also be treated with
hormones but does not contain the protein that promotes cancer cells.
Type HR-/HER2+ is commonly referred to as inflammatory breast cancer and
contains invasive ductal carcinoma. This form tends to be diagnosed at more advanced
stages. This type does not respond to hormone therapy and contains the protein that
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promotes growth. HR-/HER2- is also known as triple negative breast cancer. It is
negative for progesterone and estrogen receptors, so it is not receptive to hormone
therapy and does not contain growth-promoting proteins. Therefore, it is aggressive and
often requires a combination of therapies that can include surgery, radiation, and
chemotherapy (Howlader et al., 2014; Kohler et al., 2015). The fact that Black women
make up a large proportion of those who are diagnosed with this type of cancer may be
why the mortality rates are higher; however, research has not addressed this racial
disparity.
The Role of Socioeconomics in Breast Cancer Racial Disparities
Socioeconomics play a significant role in observed breast cancer racial disparities
(Wheeler et al., 2013). When biologic and clinical factors such as tumor type, hormone
receptor, proficiency of prognosis, stage of diagnosis, and insurance are controlled, racial
disparities are statistically significant (Wheeler et al., 2013). For example, Feinglass et
al. (2015) examined statistical relationships between socioeconomics and all-cause
mortality among women with breast cancer. Insurance coverage, race or ethnicity, stage
of cancer, treatment modalities, personal demographics, and hospital type were controlled
to determine impact. Data from 582,000 female patients between 1988 and 2006 were
obtained from the National Cancer Data Base and included follow-up through 2011 on
vital status (Feinglass et al., 2015). The sample included breast cancer patients from
1,630 hospitals that reported to the National Cancer Database. Patients’ ages were
categorized as 39 and under, 40 to 49, 50 to 69, and 70 and older. Race and ethnicity
were categorized as non-Hispanic White, non-Hispanic Black, Hispanic, Asian, and other
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or unknown. The TNM (tumor, node, metastasis) classification of malignant tumors was
used to classify stage. Treatment included primary surgery (lumpectomy, mastectomy, or
no or unknown surgery) and radiation, therapy, chemotherapy, and hormone therapy.
Treating hospitals included large urban, medium urban, small urban, rural, unknown and
academic, research, or community institutions (Feinglass et al., 2015).
To control for trends in treatment, three periods were included: 1998‒2000, 2001‒
2003, and 2004‒2006 (Feinglass et al., 2015). Hazard ratios were ranked for 16
combinations of income, education, and zip code. Zip codes were used as a proxy for
socioeconomic status, resulting in a six-level measure for socioeconomic status, which
was then grouped into five socioeconomic status categories ranging from highest income
and education to lowest income and education (Feinglass et al., 2015). A final category
included patients without insurance or Medicaid coverage (Feinglass et al., 2015).
Hierarchal Cox, proportional hazards analysis, was used to test the significance of the
socioeconomic variables when controlling for patient and hospital variables (Feinglass et
al., 2015).
Feinglass et al. (2015) found that the 5-year survival rate for the highest
socioeconomic status was 87.8% and 71.5% for the 10-year survival rate with a hazard
ratio of 1.69. The lowest socioeconomic status had a 5-year survival rate of 79.5% and a
10-year survival rate of 61.5% with a hazard ratio of 1.27 (Feinglass et al., 2015). When
comorbidities and invasive cancer types were included in the model, the results remained
the same (Feinglass et al., 2015). Results showed that insurance status, cancer stage, and
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race were essential components of socioeconomic status but only explained two-thirds of
survival disparities (Feinglass et al., 2015).
A limitation of the Feinglass et al. (2015) study was that it examined all-cause
mortality rather than cancer-specific mortality. Of note was that this significant study
examined treatment modalities, hospital types, and socioeconomic status with mortality
related to breast cancer. Results showed a hazard ratio of 1.04 in medium urban region
hospitals and .92 for rural region hospitals when compared to large urban region hospitals
(Feinglass et al., 2015). More significant were the treatment modalities. Radiation
therapy had a hazard ratio of .76 when compared to no radiation (Feinglass et al., 2015).
Chemotherapy had a hazard ratio of .87 when compared to no chemotherapy (Feinglass et
al., 2015). Hormone therapy had a hazard ratio of .72 and receipt of no surgical
interventions had a hazard ratio of 1.80 when compared to mastectomies (Feinglass et al.,
2015). In addition to correlating socioeconomic status and mortality, the study
demonstrated a correlation between hospitals (a type of health care facility), treatment
type, and mortality.
The Role of the Health care System in Breast Cancer Racial Disparities
As recently as 2016, the Office of Civil Rights and Health and Human Services
clarifying previous rulings by stating that, “Discrimination on the basis of race, color,
national origin, sex, age, or disability” in health programs is prohibited (Federal Register,
2016). Yet discrimination in health care facilities and among health care professionals is
well documented and has been litigated since the establishment of the United States
health care system (Yearby, 2014). Yearby (2015) explored how the health care system
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has been affected by racial bias implemented through structural racism, institutional
racism, and interpersonal racism. Yearby cited Jones in defining racial bias as
A system of structuring opportunity and assigning value based on the social
interpretation of how we look (which is what we call ‘race’), that unfairly
disadvantages some individuals and communities, and saps the strength of the
whole society through the waste of human resources. (Yearby, 2015, p. 3)
Racial bias has led to a government-sponsored separate and unequal health care
system (Yearby, 2015). The health care system maintained separate and unequal health
care systems at the societal (structural) level through the establishment of an ability to
pay system that provided a lesser quality of care to those who could not pay (Yearby,
2015). Social biases were augmented through organizational (institutional) structures
that prescribed racial biases through policy by exempting physicians and by extension
their health care facilities from requirements of Title VI (Yearby, 2015). If Black
patients are able to overcome structural and institutional barriers to health care, they are
likely to encounter physicians’ (interpersonal) implicit and explicit biases that have
resulted in Black patients either being denied cared, delayed care, or provided less than
recommended care (Yearby, 2015).
Health care Facilities as Barriers to Care
Despite the abundant number of studies addressing health disparities and
inequities in health care, structural forms of discrimination and their effect on health care
delivery continues to be understudied (Krieger, 2012; Molina et al., 2015; ViruellFuentes et al., 2012). Racism influences lives through segregation (Cozier et al., 2014),
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education (Wheeler, 2015), employment (Wiecek & Hamilton, 2013), and health (Phelan
& Link, 2015). There is a need to shift the focus of study from individual causes
(biology and culture) to societal level causes (racism) and how they affect the institutions
that deliver care (Gee & Ford, 2011).
A 2018 Norwegian study of hospital performance related to hospital ownership
found that hospital ownership significantly impacted emergency services, specialization,
selection of patients and quality of care (Bjorvatn, 2018). Private hospitals compared
other ownership types had reduced emergency services due to cost, increased more
profitable specialization offerings, are slightly more likely to treat patients with more comorbidities, have shorter waits, shorter stays and have more elective admissions
(Bjorvatn, 2018). This study was particularly impressive. Although the results were
mixed, it did provide a prospective different ownership types while controlling for race
(cultural differences) due to the relative heterogeneity of the Norwegian population.
Institutional Racism: Medically Underserved Areas
Massey and Denton (1993) stated that “Racial/ethnic segregation refers to the
degree to which two or more groups live separately from one another in a geographic
area.” Racial residential segregation results from a combination of socioeconomic
drivers: (a) education, income, and wealth, which can either increase or limit access to
neighborhoods with resources; (b) racial and ethnic differences based on individual
preferences to live among what is culturally identifiable; and (c) stratification resulting
from White aversion to living with minority groups; thereby reinforcing discriminatory
practices in housing (Crowder & Krysan, 2016). Whatever the driver, primary
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segregation rates between White and Black populations persistently remain high, leading
to inequitable neighborhood resources (Crowder & Krysan, 2016). Limited educational
and employment opportunities resulting from residential segregation creates pockets of
poverty that can limit access to health care resources (Butler, Petterson, Phillips, &
Bazemore, 2013). Less advantaged segregated neighborhoods are challenged
economically and socially to attract and retain qualified physicians and create medically
underserved areas (Rice, Nadig, Simpson, Ford, & Goodwin, 2014). Medically
underserved areas have been used the federal health agencies categorize areas of need
according to the physician to population ratios based on poverty and mortality rates (Rice
et al., 2014).
Historically, within the broader context of racial segregation, segregation has
played a significant role in the establishment and allocation of health care resources,
specifically health care facilities (Ko, Needleman, Derose, Laugesen, & Ponce, 2014;
Yearby, 2014). Examples of health care facility segregation, reflecting the cancer
continuum and based on location continue to be reported in geographic access to
preventative screenings such as mammograms (Khan-Gates, Ersek, Eberth, Adams, &
Pruitt, 2015), availability of breast cancer surgeons (Freedman, Kouri, West, & Keating,
2015), timely receipt of adjuvant therapy (surgery followed by chemotherapy)
(Freedman, He, Winer, & Keating, 2013), receipt of radiation therapy (Feinstein et al.,
2013), geographic variations in health care spending (Newhouse & Garber, 2013) and
access to health care resources (Akinyemiju et al., 2013) despite the enactment of Title
VI which was enacted to prevent racial discrimination in health care (Yearby, 2014).
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Structural Discrimination: Discriminatory Policies and Practices
Federal and state policies and practices have aided in the maintenance of separate
and unequal health care system (Yearby, 2015). This has been achieved through medical
redlining (Beyer et al., 2016; Yearby, 2014; Yearby, 2015) or economic credentialing, the
practice of rating physicians using economic criteria unrelated to quality or qualifications
(Byrd & Clayton, 2012; Chakravarty, 2015; Rauch et al., 2012), excessive wait times for
screening, diagnosis, and treatment (Bleicher et al., 2015; Downing, Twelves, Forman,
Lawrence, & Gilthorpe, 2014; Hamel et al., 2014; Nolan et al., 2014), insurance coverage
or the ability to pay in advance for access to health care (Gorey et al., 2013; Gorey et al.,
2015; Haji-Jama, Gorey, Luginaah, Balagurusamy, & Hamm, 2013), lack of continuity of
care (Nolan et al., 2014; Weinstein, LaNoue, Hurley, Sifri, & Myers, 2015).
America’s piecemeal approach to addressing health care disparities in race,
gender, class, and region, has resulted in separate and unequal access in the delivery of
health care (Hoffman, 2012). Hospital policies of refusing to admit patients without a
physician with admitting privileges served to restrict access further. (Casalino, 2013;
Powers, Oriol, & Jain, 2015; Rosenbaum & Sager, 2015). The Hill-Burton Act prevented
discrimination in health care but allowed for separate and equal facilities that upon
review were under resourced. The few hospitals that did allow Black patients did not
allow Black physicians (Smith, 2015).
The Hill-Burton Act and Title VI of the Civil Rights Act failed to define
discrimination clearly (Smith, 2015). While acts of overt discrimination such as giving
privileges to physicians of color and admitting Black patients were clear, the more
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insidious forms of discrimination, defined as disparate impact were less easily monitored
or addressed (Smith, 2015). Disparate impact can include the relocation of a health care
facility from a poorer neighborhood to a more affluent neighborhood for business reasons
or more subtle forms of disparate impact such as the United States having the lowest bed
count to population ratio than any other country (Smith, 2015). On its face, this policy
appears neutral until you consider that a lower bed count means shorter hospital stays.
Shorter hospital stays require patients to have the resources available in their
neighborhood for adequate home care. Lower income patients, typically Black and
Hispanic patients, have less access to adequate home care than more affluent, typically
White, patients do (Smith, 2015).
Intrapersonal Discrimination: Lack of Culturally Competent Care
Physician bias repeatedly has been shown to be inversely related to poor health
outcomes a reflection of ineffective communication, treatment decisions, and biased
perceptions (Chapman, Kaatz, & Carnes, 2013; Cooper et al., 2012; Sabin & Greenwald,
2012; Staats & Patton, 2013; Zestcott, Blair, & Stone, 2016). The studies, however,
ignore structural and institutionalized racism as a factor in contributing to implicit and
explicit biases. This commonly accepted sociological approach misses the forest because
it is too intently focused on the tree suggesting that an individual within a system can act
independently of the system. Notwithstanding the overwhelming evidence illustrating
that adverse health outcomes are inversely correlated with physician bias, two notable
studies suggested that physician bias has no meaningful impact on health outcomes (Blair
et al., 2014; Penner, Blair, Albrecht, & Dovidio, 2014). Their findings suggest that
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physicians are capable of concurrently holding implicit biases while behaving explicitly
as egalitarians.
Unique Experience of Black Women
Black women have a unique experience in the health care system. Patients who
are members of more than one social category experience intersectionality (Bowleg,
2012). Although it has been demonstrated that individual social groups experience
adverse health outcomes resulting from racial bias in health care, few studies have
examined how belonging to multiple social categories, such as being both Black and
female, can affect health outcomes, (Bowleg, 2012; Hankivsky, 2012). Originating in the
Black feminist movement, intersectionality attempted to address how Black women fared
differently in social institutions than being solely a woman or solely Black (Bowleg,
2012). Black women even with higher social achievement still do not fare as well as
White women with equivalent social achievement, indicating that other factors are
involved (Klassen, Pankiewicz, & Curriero, 2013; Klassen, Pankiewicz, Hsieh, Ward, &
Curriero, 2015). Black women are subjected to a two-fold health outcome setback due to
a combination of two adverse characteristics subjected to both racial and sexual bias
(Klassen et al., 2013; Klassen et al., 2015).
Summary
A racially biased social and political system has led to health care facilities that
reflect institutional bias through medically underserved areas, structural discrimination
through discriminatory policies and practices, and interpersonal discrimination through
culturally incompetent care. When social and political factors are compounded by
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socioeconomics and tumor type, the result is disparate breast mortality outcomes between
Black and White women. Using data from the Georgia Center for Cancer Statistics and
the American Hospital Association, in the proposed study I will examine the influence of
selected characteristics of health care facilities on the disparate breast mortality outcomes
between Black and White women. The methods that will be used to answer the research
question are outlined in Chapter 3.
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Chapter 3: Methodology
The purpose of this study was to determine whether selected characteristics of
health care facilities can predict breast cancer survival rates. Race was a proxy for
culture, income was a proxy for poverty, and hospital ownership/control was a proxy for
social justice factors. Culture, poverty, and social justice were factors chosen from
Freeman and Chu’s (2005) framework for social determinants of health inequalities for
cancer. The research questions for the study were designed to examine variables as
predictors of breast cancer mortality rates and explain which variables exert significant
influences. Based on the criteria of the study, a quantitative research design was chosen.
To examine the relationship between breast cancer survival and predictors of race,
income, health care facility type, grade, and tumor type (four subvariables), the following
analyses were performed: Kaplan-Meier method, log-rank tests, and Cox proportional
hazards model (see Kleinbaum & Klein, 2012).
This chapter includes a discussion of the quantitative methods related to research
design, population demographics, sampling procedure, ethical considerations, research
questions and hypotheses, data collection, the operationalization of variables, and
description of data analysis used to address the research objectives.
Research Design
The approach in this study was quantitative with a retrospective cohort design,
which was used to study whether the common exposure factors of health care facilities,
income, and race are predictive of breast cancer survival outcomes between Black and
White women. The population, sampling procedure, ethics, study questions, data
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collection, the operationalization of variables, and data analysis will be outlined in the
following sections.
Population
The population for this study consisted of White women and Black women
between the ages of 45 and 69 residing in the state of Georgia who were diagnosed with
breast cancer between January 1, 2009, and December 31, 2014. If there were two or
more diagnoses of breast cancer (indicating relapse), only the initial diagnosis was used.
Records were excluded if they were incomplete, such as missing relevant demographic or
survival information. This population was chosen because the incidence of breast cancer
increases significantly in both Black and White women at the age of 45 and peaks at 69,
with the median age being 65 (Howlader, Noone, & Krapcho, 2016). The initial
diagnosis was examined because a patient in relapse indicates a patient already in
treatment versus a woman entering the health care system to be diagnosed. Additionally,
identification of stages at diagnosis helps to clarify when patients are being diagnosed.
Data of 6,178 patients were provided. The following observations were removed
from the analysis
•

Observations with unwanted categories for variables related to breast cancer
survival (i.e., observations with responses = “4” for grade).

•

Observations with missing/unknown values for variables related to breast
cancer survival, including
o Responses = “9” for race and grade,
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o Responses = “996” (Test ordered, results not interpretable), “997” (Test
ordered, results not in chart), “998” (Test not done (not ordered or
performed)), “988” (Not applicable: Information not collected for this
case), and “999” (Unknown, no information provided) for the four
variables for tumor type.
The final data set contained 4,087 patients.
Sampling and Sampling Procedures
Records were extracted from the Georgia Cancer Registry based on defined
criteria. Criteria for inclusion were race (White, Black) gender (female) age (45-69), year
of initial diagnosis (2009-20014), and cancer grades (I, II, III). Additional criteria
included diagnostic confirmation method (microscopically, positive laboratory
test/marker study, direct visualization without microscopic confirmation, radiography
without microscopic confirm, clinical diagnosis only), reporting source (hospital;
radiation treatment center/medical oncology center, hospital affiliated; laboratory,
hospital affiliated,;other hospital outpatient units/surgery centers), SEER summary stage
2000 (in situ, localized, regional, distant site node), molecular subtype, census tract
poverty indicator, marital status, cause of death, and treatment variables. I restricted the
analysis to only those cancers meeting the above criteria where a single hospital was
involved in both the diagnosis and first course treatment of the cancer patient. Finally, I
linked registry records to an AHA Georgia hospital list using National Provider Identifier
numbers for my variable of interest (control/ownership type).
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Data Access
To access the data of the Georgia Cancer Registry, I completed an online form
and submitted to the Georgia Department of Public Health. This required initial contact
with Emory University. Emory University acts as the principal investigator for the
Georgia Cancer Registry. The process is to submit an initial application and study
abstract to Emory University for review. Included in the application is the requested data
and data parameters.
Ethical Considerations
This study required approval from the Institutional Review Board (IRB) of
Walden University. An application was submitted for IRB approval before data
collection. In addition to IRB approval from Walden University), IRB approval from the
Georgia State Department of Public Health (approval no. 108609) was obtained to access
the data stored in the Georgia Cancer Registry. Additionally, I signed the registry’s Data
Use Agreement to access and govern the use of the data. Although there was no direct
contact with human subjects, personal protected information patient data were used and
therefore required IRB approval.
Several measures were implemented to ensure the protection of human subjects.
First, HIPAA protected data were stored in an encrypted laptop. I used Bitlocker, which
is a full disk encryption using AES encryption algorithm using a 256-bit key, to encrypt
my entire laptop. Second, per 45 CFR 164.528 I will retain records for a minimum of 6
years. After the required retention period stored data will be destroyed using Eraser, an
advanced security tool for Windows that completely removes sensitive data from the hard
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drive by overwriting it several times. The laptop will then be taken to a county
government facility for electronic hardware destruction. I have been educated on HIPAA
regulations and how to handle personal health information. No identifiable information
will be used in the dissertation. No codes will be created that could link a subject to the
data collected and recorded. Any patient lists created will be destroyed at the earliest
opportunity consistent with the conduct of the research. I was the only one with access to
the data.
Research Questions and Hypothesis
The central research question was: Do poverty, culture, and social justice affect
the breast cancer survival rate of Black and White women in Georgia? The following are
the research questions and hypotheses that guided the study?
Research Question 1: Is poverty (income) a determinant of the breast cancer
survival rate of Black and White women in Georgia?
H01: Poverty is not a determinant of the breast cancer survival rate of Black
and White women in Georgia.
Ha1: Poverty is a determinant of the breast cancer survival rate of Black and
White women in Georgia.
Research Question 2: Is culture (race) a determinant of the breast cancer survival
rate of Black and White women in Georgia?
H02: Culture is not a determinant of the breast cancer survival rate of Black
and White women in Georgia.
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Ha2: Culture is a determinant of the breast cancer survival rate of Black and
White women in Georgia.
Research Question 3: Is social justice (a type of health care facility) a determinant
of the breast cancer survival rate of Black and White women in Georgia?
H03: Social justice is not a determinant of the breast cancer survival rate of
Black and White women in Georgia.
Ha3: Social justice is a determinant of the breast cancer survival rate of Black
and White women in Georgia.
Research Question 4: What is the relationship between poverty, culture, and
social justice as a determinant of the breast cancer survival rate of Black and
White women in Georgia?
H04: None of the independent variables (poverty, culture, and social justice)
have a statistically significant relationship on breast cancer survival rates of
Black and White women in Georgia.
Ha4: The independent variables (poverty, culture, and social justice) have a
statistically significant relationship on breast cancer survival rates of Black
and White women in Georgia.
Data Collection
This is a secondary data analysis. Data were analyzed using SAS version 9.4
(SAS Institute Inc., Cary, NC). The data for this study will be collected from the Georgia
Cancer Registry and the American Hospital Association. The Georgia Cancer Registry is
a cancer registry managed by Emory University. The Georgia Cancer Registry contains
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comprehensive population data on stage of cancer, patient survival, and patient
demographics specific to the state of Georgia.
Operationalization of Variables
The following are the study variables and how they will be operationalized in the
study.
•

Survival time (days): a continuous variable, computed as the difference between
“date of last contact” and “date of diagnosis.”

•

Status: a categorical variable with two levels (1 (event or death) vs. 0 (censored))
- According to the data set provided, the study time ended at 2018/02/19. Thus,
(1) a patient did not experience the event (death) before the study ended, and (2) a
person was lost to follow-up during the study period, were both considered
“censored.”

•

Race: a categorical variable with two levels (Black vs. White)

•

Income: a categorical variable with 4 levels based on Census Track Poverty
Indicator (1 = 0% - < 5% poverty, 2 = 5% - <10% poverty, 3 = 10% - <20%
poverty, 4 = 20% - 100% poverty)

•

Health care facility type, a categorical variable with three levels (Nonprofit, forprofit, and government)

•

Grade: a categorical variable with three levels (I, II, and III)

•

Tumor type: 4 variables were considered, including
o Estrogen receptor (ER) assay (luminal A breast cancer), a categorical
variable with two levels (ER positive vs. Not ER positive)
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o Progesterone receptor (PR) assay (luminal B breast cancer), a categorical
variable with two levels (PR positive vs. Not PR positive)
o HER2 results (HER2 type breast cancer): a categorical variable with two
levels (HER2 positive vs. Not HER2 positive)
o Combinations of ER, PR, and HER2 results (triple-negative breast cancer),
a categorical variable with two levels (Triple negative vs. Not triple
negative)
Data Analysis
Data were analyzed using SAS version 9.4 (SAS Institute Inc., Cary, NC).
Demographic profiles of each hospital type were summarized using frequency tables.
To examine the relationship between breast cancer survival and predictors of
interest, including race, income, health care facility type, grade, and tumor type (4 subvariables), the following analyses were performed, including, Kaplan-Meier method, logrank tests, and Cox proportional hazards model (Kleinbaum and Klein, 2012).
For each predictor, without considering the effects of other predictors, KaplanMeier method was used to estimate and graph the survival curves for different groups
(ex: for race, there were two groups, Black and White). Log-rank tests were used to test if
there was a statistically significant difference in the survival functions. For predictors
with more than two categories, i.e., income, health care facility type, and grade, if the
results of log-rank tests were significant, pairwise comparisons were performed to see
which two categories had statistically significantly different survival curves. To control
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for the family wise error rate, the multiple comparison procedure, the Tukey-Kramer
method (Kramer, 1956), was implemented.
A Cox, proportional hazards model, was implemented to determine the effect of
each predictor on breast cancer survival after considering the effects of other predictors.
Wald chi-square tests were used to determine if the effects of the predictors were
significant. For predictors with more than two categories, i.e., income, health care facility
type, and grade, if the results were significant, pairwise comparisons were performed to
see which two categories had statistically significantly different survival curves. To
control for the family wise error rate, the multiple comparison procedure, the TukeyKramer method (Kramer, 1956), was implemented. Hazard ratios and the associated 95%
confidence intervals were reported as a measure of the effect of each predictor. The
proportional hazards assumption was examined using the graphical method of Lin, Wei,
and Ying (1993) for checking the adequacy of the Cox, regression model. The
assumption was satisfied. For all tests, a p-value less than 0.05 was considered
significant.
Threats to Validity
Several primary variables of interest race and income are ascertained either
through medical record or respondent survey; therefore, some self-reporting bias may
exist. However, the magnitude of the study should limit the impact of this bias. Another
important threat to validity is that the Georgia Cancer Registry does not report adjuvant
therapies such as chemo-therapy and hormone therapy. As stated in the literature review,
both of these therapies should be offered to women with breast cancer per national
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recommendations; therefore, inequitable access to these adjuvant therapies could
potentially lead to disparate survival rates.
Summary
The purpose of Chapter 3 was to delineate the methodology of the study. This
chapter contains a description of the research design, target population, sampling and
sampling procedures, ethical considerations, research questions and hypothesis, data
collection, the operationalization of variables, data analysis, and threats to validity.
Chapter 4 will present findings from the analysis of data.
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Chapter 4: Results
The purpose of this study was to determine breast cancer survival and race,
income, health care facility type, grade, and tumor type. I also examined the
demographic profile of each health care facility type. The current chapter will present the
data and its analyses. First, the chapter will include the study variables and the
demographic variables collected from the Georgia Cancer Registry. Then the data
analysis methods will be presented before the data analysis results. This analysis allowed
for the examination of the impact of health facilities on breast cancer survival rates of
Black and White women in Georgia.
Data Collection
The study variables related to breast cancer survival were as follows:
•

Survival time (days): a continuous variable, computed as the difference
between “date of last contact” and “date of diagnosis.”

•

Status: a categorical variable with two levels (1 [event or death] and 0
[censored])
o According to the data set provided, the study time ended at 2018/02/19.
Thus, (a) a patient did not experience the event (death) before the study
ended, and (b) a person was lost to follow-up during the study period,
were both considered “censored.”

•

Race: a categorical variable with two levels (Black and White)
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•

Income: a categorical variable with 4 levels based on Census Track Poverty
Indicator (1 = 0% - < 5% poverty, 2 = 5% - <10% poverty, 3 = 10% - <20%
poverty, 4 = 20% - 100% poverty

•

Health care facility type, a categorical variable with three levels (nonprofit,
for-profit, and government)

•

Grade: a categorical variable with three levels (I, II, and III)

•

Tumor type: four variables were considered, including
o Estrogen receptor (ER) assay (luminal A breast cancer), a categorical
variable with two levels (ER positive vs. Not ER positive)
o Progesterone receptor (PR) assay (luminal B breast cancer), a categorical
variable with two levels (PR positive vs. Not PR positive)
o HER2 results (HER2 type breast cancer): a categorical variable with two
levels (HER2 positive vs. Not HER2 positive)
o Combinations of ER, PR, and HER2 results (triple-negative breast cancer),
a categorical variable with two levels (Triple negative vs. Not triple
negative)

The demographic variables of interest were as follows:
•

Personal demographics: martial status, race, age at diagnosis, income, and
laterality

•

Grade: grade and diagnosis confirmation

•

Tumor type: luminal A breast cancer, luminal B breast cancer, HER2 type
breast cancer, triple-negative breast cancer

45
•

Treatment summary: type of surgery to the primary site performed,
chemotherapy given as part of the first course of treatment, sequencing of
radiation and surgery given as part of the first course of treatment, whether
systemic hormonal agents were administered as first-course treatment at any
facility, whether immunotherapeutic (biologic response modifiers) agents
were administered as first course treatment at all facilities
Methods

Data were analyzed using SAS version 9.4. Demographic profiles of each
hospital type were summarized using frequency tables. To examine the relationship
between breast cancer survival and race, income, health care facility type, grade, and
tumor type (four subvariables), the following analyses were performed: Kaplan-Meier
method, log-rank tests, and Cox proportional hazards model (see Kleinbaum & Klein,
2012). For each predictor, without considering the effects of other predictors, KaplanMeier method was used to estimate and graph the survival curves for different groups
(e.g., for race, there were two groups: Black and White). Log-rank tests were used to test
if there was a statistically significant difference in the survival functions. For predictors
with more than two categories (i.e., income, health care facility type, and grade) if the
results of log-rank tests were significant, pairwise comparisons were performed to see
which two categories had statistically significantly different survival curves. To control
for the family wise error rate, the multiple comparison procedure, the Tukey-Kramer
method was implemented (see Kramer, 1956).
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A Cox, proportional hazards model, was implemented to determine the effect of
each predictor on breast cancer survival after considering the effects of other predictors.
Wald chi-square tests were used to determine if the effects of the predictors were
significant. Hazard ratios and the associated 95% confidence intervals were reported as a
measure of the effect of each predictor. The proportional hazards assumption was
examined using the graphical method of Lin, Wei, and Ying (1993) for checking the
adequacy of the Cox, regression model. The assumption was satisfied. For all tests, a pvalue less than 0.05 was considered significant.
Analysis Results
Tables 1-4 present the demographic profiles of each hospital type. Regarding
personal demographics (Table 1), for each hospital type, over half of the patients were
married (61.72% for for-profit, 55.12% for nonprofit, and 50.44% for government), a
majority of the patients were White (73.42% for for-profit, 69.26% for nonprofit, and
60.62% for government), and slightly under half of the patients were over 60 years-old
(46.20% for for-profit, 45.90% for nonprofit, and 45.48% for government). For for-profit
hospitals, 39.56% of the patients were 10% - <20% poverty; for nonprofit hospitals,
52.25% of the patients were 20%-100% poverty; and for government-run hospitals,
40.72% of the patients were 20%-100% poverty. Regarding laterality, over half of the
patients were 1 for for-profit hospitals (52.22%) and 2 for nonprofit hospitals (53.89%)
and government-run hospitals (52.54%).
Regarding grade (Table 2), for each hospital type, the distributions of patients
were almost equal among the three levels of tumor grade. Almost all patients’ diagnosis
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confirmation was based on positive histology (100% for for-profit, 99.80% for nonprofit,
and 99.39% for government).
Regarding tumor type (Table 3), regarding the test results of luminal A breast
cancer, for each hospital, most of the patients were ER positive (83.54% for for-profit,
78.69% for nonprofit, and 78.86% for government). Regarding the test results of luminal
B breast cancer, around 70% of the patients were PR positive (68.35% for for-profit,
69.06% for nonprofit, and 67.93% for government). Regarding the test results of HER2
type breast cancer, over 80% of the patients were not HER2 positive (81.65% for forprofit, 81.15% for nonprofit, and 82.24% for government). Regarding test results of
triple-negative breast cancer, approximately 10-15% of the patients were triple negative
(10.76% for for-profit, 13.52% for nonprofit, and 14.74% for government).
Regarding treatment summary (Table 4), for each hospital, over 90% of patients
had surgery to the primary site performed (93.99% for for-profit, 95.08% for nonprofit,
and 91.90% for government). Regarding chemotherapy, over 60% of the patients in forprofit hospitals (64.87%) were not given chemotherapy, whereas only around half of the
patients in the nonprofit (48.77%) and government-run hospitals (53.55%) were not given
chemotherapy. A slightly higher percentage of patients in the for-profit hospitals were
not given sequencing of radiation, in comparison to patients in the nonprofit and
government-run hospitals (55.38% for for-profit, 44.06% for nonprofit, and 49.41% for
government). A slightly higher percentage of patients in the for-profit hospitals were not
given systemic hormonal agents, in comparison to patients in the nonprofit and
government-run hospitals (48.10% for for-profit, 36.89% for nonprofit, and 36.22% for
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government). A majority of the patients were not given immunotherapeutic agents
(94.30% for for-profit, 92.01% for nonprofit, and 92.72% for government).

49
Table 1
Demographic Profiles (Personal Demographics) by Hospital Type

Marital status

Race
Age

Income

Laterality

Single
Married
Separated
Divorced
Widowed
Unknown
White
Black
45-49
50-54
55-59
60+
0% - <5% poverty
5% - <10% poverty
10% - <20% poverty
20% - 100% poverty
1
2
4
Unknown

For-profit
(N = 316)
37 (11.71)
195 (61.72)
1 (0.32)
48 (15.19)
26 (8.23)
8 (2.53)
232 (73.42)
84 (26.58)
40 (12.66)
63 (19.94)
67 (21.20)
146 (46.20)
24 (7.59)
90 (28.48)
125 (39.56)
77 (24.37)
165 (52.22)
150 (47.47)
1 (0.32)
0

Nonprofit
(N = 488)
51 (10.45)
269 (55.12)
5 (1.02)
81 (16.60)
47 (9.63)
35 (7.17)
338 (69.26)
150 (30.74)
72 (14.75)
86 (17.62)
106 (21.72)
224 (45.90)
12 (2.46)
40 (8.20)
181 (37.09)
255 (52.25)
224 (45.90)
263 (53.89)
0
1 (0.20)

Government
(N = 3283)
605 (18.43)
1656 (50.44)
74 (2.25)
527 (16.05)
288 (8.77)
129 (3.93)
1990 (60.62)
1293 (39.38)
495 (15.08)
581 (17.70)
714 (21.75)
1493 (45.48)
394 (12.00)
593 (18.06)
959 (29.21)
1337 (40.72)
1558 (47.46)
1725 (52.54)
0
0
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Table 2
Demographic Profiles (Grade) by Hospital Type

Grade

Diagnosis
confirmation

I
II
III
Positive histology
Positive cytology, no
positive histology
Unknown whether or
not microscopically
confirmed

For-profit
(N = 316)
75 (23.73)
122 (38.61)
119 (37.66)
316 (100.0)

Nonprofit
(N = 488)
117 (23.98)
173 (35.45)
198 (40.57)
487 (99.80)

Government
(N = 3283)
743 (22.63)
1408 (42.89)
1132 (34.48)
3263 (99.39)

0

0

20 (0.61)

0

1 (0.20)

0

Table 3
Demographic Profiles (Tumor Type) by Hospital Type

ER assay
PR assay
HER2 results

Combination of
ER, PR, and HER2

ER positive
Not ER positive
PR positive
Not PR positive
HER2 positive
Not HER2
positive
Triple negative
Not triple negative

For-profit
(N = 316)
264 (83.54)
52 (16.46)
216 (68.35)
100 (31.65)
58 (18.35)
258 (81.65)

Nonprofit
(N = 488)
384 (78.69)
104 (21.31)
151 (30.94)
337 (69.06)
92 (18.85)
396 (81.15)

Government
(N = 3283)
2589 (78.86)
694 (21.14)
1053 (32.07)
2230 (67.93)
583 (17.76)
2700 (82.24)

34 (10.76)

66 (13.52)

484 (14.74)

282 (89.24)

422 (86.48)

2799 (85.26)
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Table 4
Demographic Profiles (Treatment summary) by Hospital Type

Surgery to the primary site
performed

Chemotherapy

Sequencing of radiation

Systemic hormonal agents

Immunotherapeutic agents

No

For-profit
(N = 316)
19 (6.01)

Nonprofit
(N = 488)
24 (4.92)

Government
(N = 3283)
266 (8.10)

Yes
Unknown
No
Yes
Unknown
No
Yes
Unknown
No
Yes
Unknown
No
Yes
Unknown

297 (93.99)
0
205 (64.87)
111 (35.13)
0
175 (55.38)
141 (44.62)
0
152 (48.10)
155 (49.05)
9 (2.85)
298 (94.30)
18 (5.70)
0

464 (95.08)
0
238 (48.77)
249 (51.02)
1 (0.2)
215 (44.06)
273 (55.94)
0
180 (36.89)
286 (58.61)
22 (4.51)
449 (92.01)
38 (7.79)
1 (0.20)

3017 (91.90)
0
1758 (53.55)
1518 (46.24)
7 (0.21)
1622 (49.41)
1661 (50.59)
0
1189 (36.22)
1953 (59.49)
141 (4.29)
3044 (92.72)
236 (7.19)
3 (0.09)
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Figure 1. Kaplan-Meier survival curves, by race.

Figure 2. Kaplan-Meier survival curves, by income.
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Figure 3. Kaplan-Meier survival curves, by health care facility type.

Figure 4. Kaplan-Meier survival curves, by grade.
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Figure 5. Kaplan-Meier survival curves, by tumor type (ER assay).

Figure 6. Kaplan-Meier survival curves, by tumor type (PR assay).
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Figure 7. Kaplan-Meier survival curves, by tumor type (HER2).

Figure 8. Kaplan-Meier survival curves, by tumor type (triple negative).
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Figures 1-8 present the Kaplan-Meier survival curves, by race, income, health
care facility, grade, and tumor types. The results of log-rank tests (Table 5) suggested that
there was a statistically significant difference in the survival functions between White and
Black (χ2(1) = 37.9244, p < 0.0001). The estimated 5-year survival probability was
0.8648 for White and 0.7833 for Black.
There was a statistically significant difference in the survival functions among
patients with different income level (χ2(3) = 21.5580, p < 0.0001). The estimated 5-year
survival probability was 0.8698 for 0-<5% poverty, 0.8731 for 5-<10% poverty, 0.8418
for 10-<20% poverty, and 0.8020 for 20-100% poverty. The results of pairwise
comparisons (Table 6) further suggested that there was a statistically significant
difference in the survival functions between 0% - <5% poverty and 20% - 100% poverty
(χ2(1) = 18.8820, p < 0.0001). There was a statistically significant difference in the
survival functions between 10% - <20% poverty and 20% - 100% poverty (χ2(1) =
10.8893, p < 0.0001). There was a statistically significant difference in the survival
functions between 5% - <10% poverty and 20% - 100% poverty (χ2(1) = 17.9979, p <
0.0001).
There was no statistically significant difference in the survival functions among
patients in different health care facilities (χ2(2) = 0.0150, p = 0.9926). There was a
statistically significant difference in the survival functions among patients with different
tumor grade (χ2(2) = 101.5461, p < 0.0001).
The estimated 5-year survival probability was 0.9235 for tumor grade I, 0.8409
for tumor grade II, and 0.7686 for tumor grade III. The results of pairwise comparisons
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(Table 6) further suggested that there was a statistically significant difference in the
survival functions between patients with tumor grade I and patients with tumor grade II
(χ2(1) = 9.4944, p = 0.0058). There was a statistically significant difference in the
survival functions between patients with tumor grade I and patients with tumor grade III
(χ2(1) = 110.4, p < 0.0001). There was a statistically significant difference in the survival
functions between patients with tumor grade IIII and patients with tumor grade II (χ2(1) =
39.5249, p < 0.0001).
There was a statistically significant difference in the survival functions between
patients who were ER positive and patients who were not ER positive (χ2(1) = 70.9905, p
< 0.0001). The estimated 5-year survival probability was 0.8588 for patients who were
ER positive and 0.7392 for patients who were not ER positive. There was a statistically
significant difference in the survival functions between patients who were PR positive
and patients who were not PR positive (χ2(1) = 84.1358, p < 0.0001). The estimated 5year survival probability was 0.8712 for patients who were PR positive and 0.7549 for
patients who were not PR positive. There was a statistically significant difference in the
survival functions between patients who were HER2 positive and patients who were not
HER2 positive (χ2(1) = 4.8464, p = 0.0277). The estimated 5-year survival probability
was 0.8081 for patients who were HER2 positive and 0.8394 for patients who were not
HER2 positive. There was a statistically significant difference in the survival functions
between patients who were triple negative and patients who were not triple negative
(χ2(1) = 72.5394, p < 0.0001). The estimated 5-year survival probability was 0.7136 for
patients who were triple negative and 0.8547 for patients who were not triple negative.
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Table 5
Results of Log-Rank Tests

Race
Income

Facility

Grade

Tumor type (ER
assay)
Tumor type (PR
assay)
Tumor type
(HER2 assay)

Tumor type
(triple negative)

5-year (1825 days)
survival probability
0.8648
0.7833
0.8698

White
Black
0% - <5%
poverty
5% - <10%
poverty
10% - <20%
poverty
20% - 100%
poverty
Nonprofit
For-profit
Government
I
II
III
ER positive

0.8333
0.8540
0.8207
0.9235
0.8409
0.7686
0.8588

Not ER positive
PR positive

Results of log-rank test
χ2
DF
p
37.9244

1

< 0.0001*

21.5580

3

< 0.0001*

0.0150

2

0.9926

101.5461

2

< 0.0001*

70.9905

1

< 0.0001*

0.7392
0.8712

84.1358

1

< 0.0001*

Not PR positive
HER2 positive

0.7549
0.8081

4.8464

1

0.0277*

Not HER2
positive
Triple negative

0.8394
72.5394

1

< 0.0001*

Not triple
negative

0.8547

0.8731
0.8418
0.8020

0.7136

Note. * indicates significance at the 0.05 level.
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Table 6
Results of Pairwise Comparisons
Pairwise comparison
Income 0% - <5% poverty vs. 10% - <20% poverty
0% - <5% poverty vs. 20% - 100% poverty

Grade

χ2
DF
0.0059 1
18.8820 1

0% - <5% poverty vs. 5% - <10% poverty
10% - <20% poverty vs. 20% - 100%
poverty
10% - <20% poverty vs. 5% - <10% poverty
20% - 100% poverty vs. 5% - <10% poverty

0.2765 1
10.8893 1

I vs. II
I vs. III

9.4944
110.4

II vs. III

39.5249 1

0.2237 1
17.9979 1
1
1

p
0.9998
<
0.0001*
0.9529
0.0053*
0.9650
<
0.0001*
0.0058*
<
0.0001*
<
0.0001*

Note. * indicates significance at the 0.05 level.
The results of the Cox proportional odds model are displayed in Table 7 and 8. The
analysis results of the Cox model indicated that
•

There was a statistically significant relationship between breast cancer survival
and race, after controlling for other predictors (χ2(1) = 8.0432, p = 0.0046; Table
7). In particular, the hazard of death for Black was 1.2703 times of the hazard for
White (Hazard ratio = 1.2703, 95% CI = 1.0767, 1.4987; Table 8).

•

There was no statistically significant relationship between breast cancer survival
and income, after controlling for other predictors (χ2(3) = 7.0416, p = 0.0706;
Table 7).
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•

There was no statistically significant relationship between breast cancer survival
and health care facility type, after controlling for other predictors (χ2(2) = 0.3647,
p = 0.8333; Table 7).

•

There was a statistically significant relationship between breast cancer survival
and tumor grade, after controlling for other predictors (χ2(2) = 43.6036, p <
0.0001; Table 7). In particular, the hazard of death for patients with grade I tumor
was 0.4442 times of the hazard for patients with grade II tumor (Hazard ratio =
0.4442, 95% CI = 0.3205, 0.6155); the hazard of death for patients with grade I
tumor was 0.3797 times of the hazard for patients with grade III tumor (Hazard
ratio = 0.3797, 95% CI = 0.2680, 0.5380; Table 8).

•

There was no statistically significant relationship between breast cancer survival
and tumor type (ER assay), after controlling for other predictors (χ2(1) = 0.5658, p
= 0.4520; Table 7).

•

There was a statistically significant relationship between breast cancer survival
and tumor type (PR assay), after controlling for other predictors (χ2(1) = 8.1559, p
= 0.0043; Table 7). In particular, the hazard of death for patients who were PR
positive was 1.3858 times of the hazard for patients who were not PR positive
(Hazard ratio = 1.3858, 95% CI = 1.1078, 1.7337; Table 8).

•

There was no statistically significant relationship between breast cancer survival
and tumor type (HER2 assay), after controlling for other predictors (χ2(1) =
0.2073, p = 0.6489; Table 7).
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•

There was no statistically significant relationship between breast cancer survival
and tumor type (triple negative), after controlling for other predictors (χ2(1) =
3.0748, p = 0.0795; Table 7).

Table 7
Testing Results of the Cox Model
Variable
DF
Wald chi-square
Race
1
8.0432
Income
3
7.0416
Facility
2
0.3647
Grade
2
43.6036
Tumor type (ER assay)
1
0.5658
Tumor type (PR assay)
1
8.1559
Tumor type (HER2 assay) 1
0.2073
Tumor type (triple
1
3.0748
negative)
Note. * indicates significance at the 0.05 level.

p
0.0046*
0.0706
0.8333
< 0.0001*
0.4520
0.0043*
0.6489
0.0795
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Table 8
Hazard Ratios
Variable
Race
Income

Facility

Grade

Tumor type
(ER assay)
Tumor type
(PR assay)
Tumor type
(HER2
assay)
Tumor type
(triple
negative)

Category
Black
0% - <5% poverty
0% - <5% poverty
0% - <5% poverty
10% - <20% poverty
10% - <20% poverty
20% - 100% poverty
For-profit
For-profit
Government
I
I
II
ER positive

Reference category
White
10% - <20% poverty
20% - 100% poverty
5% - <10% poverty
20% - 100% poverty
5% - <10% poverty
5% - <10% poverty
Government
Nonprofit
Nonprofit
II
III
III
Not ER positive

Hazard ratio
1.2703
0.9689
0.8010
1.0381
0.8267
1.0714
1.2961
1.0613
1.0891
1.0262
0.4442
0.3797
0.8548
1.1411

95% CI
(1.0767, 1.4987)*
(0.6472, 1.4505)
(0.5395, 1.1891)
(0.6692, 1.6106)
(0.6511, 1.0496)
(0.7745, 1.4822)
(0.9487, 1.7705)
(0.7454, 1.5110)
(0.8185, 1.4492)
(0.8062, 1.3063)
(0.3205, 0.6155)*
(0.2680, 0.5380)*
(0.6876, 1.0627)
(0.8090, 1.6097)

PR positive

Not PR positive

1.3858

(1.1078, 1.7337)*

HER2 positive

Not HER2 positive

1.0569

(0.8329, 1.3410)

Triple negative

Not triple negative

0.7090

(0.4827, 1.0413)

Note. CI = confidence interval. 95% CI was adjusted by the Tukey-Kramer method. *
indicates hazard ratio was significantly different from 1 at the 0.05 level.
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The Cox proportional odds model assumes that the hazard ratio comparing any
two specifications of predictors is constant over time (Kleinbaum and Klein, 2012). The
proportional hazards assumption was examined using the graphical method of Lin, Wei,
and Ying (1993) for checking the adequacy of the Cox regression model.
For each covariate, a graphical display of the empirical score process was created,
which is based on the martingale residuals. Figures 9-20 display the graphs for the
covariates in the Cox model. For each figure, the solid line is the observed empirical
score process. The dashed lines are empirical score processes based on 20 random
simulations that embody the proportional hazards assumption. If the observed process
deviates markedly from the simulated processes, it is evidence against the proportional
hazards assumption. Among the 12 figures, the observed process for, Facility
(government vs. nonprofit; Figure 14), Grade (II vs. III; Figure 16), Tumor type (ER
assay (ER positive vs. not ER positive; Figure 17), Tumor type (PR assay (PR positive
vs. not PR positive; Figure 18), and Tumor type (triple negative (triple negative vs. not
triple negative; Figure 20), was more extreme than the simulated processes. However, as
recommended by Kleinbaum and Klein (2012), one should use a conservative strategy for
this decision by assuming the proportional odds assumption is satisfied unless there is
strong evidence of nonparallelism of observed and simulated processes are strongly
discrepant. Therefore, using a conservative strategy, we concluded that the proportional
odds assumption was satisfied and the use of the Cox model was appropriate for the
study.
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Figure 9. Race (Black vs. White).

Figure 10. Income (0%-<5% poverty vs. 5% - <10% poverty).
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Figure 11. Income (10%-<20% poverty vs. 5% - <10% poverty).

Figure 12. Income (20%-100% poverty vs. 5% - <10% poverty).
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Figure 13. Facility (for-profit vs. nonprofit).

Figure 14. Facility (government vs. nonprofit).
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Figure 15. Grade (I vs. III).

Figure 16. Grade (II vs. III).
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Figure 17. Tumor type (ER assay [ER positive vs. not ER positive]).

Figure 18. Tumor type (PR assay [PR positive vs. not PR positive]).
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Figure 19. Tumor type (HER2 assay [HER2 positive vs. not HER2 positive]).

Figure 20. Tumor type (triple negative [triple negative vs. not triple negative]).
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Summary
Black women continue to suffer increased mortality compared to White woman,
despite socioeconomic interventions. Chapter 4 presented the results of the study. The
results showed that there is no statistically significant difference in the survival function
among patients in different health care facilities. The results did confirm previously
published correlations between race, income, and tumor grade. Chapter 5 interprets the
findings, limitations of the study, social implications, and recommendations for further
research.
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Chapter 5: Summary, Conclusion, and Recommendations
Moya Zakia Bailey (2013) in her graduate thesis coined the term Misogynor. She
used the term to refer to the intersectionality of sex and race of Black women:
Misogynoir is a term I created during my exams to express the specific ways in
which Black women (cis and trans) are targeted within popular culture. The term
is a combination of misogyny, the hatred of women and noir, which means black
but also carries film and media connotations. It is the particular amalgamation of
anti-black racism and misogyny in popular media and culture that targets black
trans and cis women. (p. 26)
Although the term misogynoir was used by Bailey to discuss how Black woman are
negatively targeted by media, the term is appropriate in other settings where Black
women suffer adverse consequences resulting from a combined bias against their gender
and race—for example, Serena Williams’s health concerns being dismissed (Salam,
2018). In relation to the current study, Black women with breast cancer report having to
advocate to obtain information regarding treatment-related symptoms and treatment risks
as well as for medication to treat symptoms (Samuel et al., 2018). Additionally, Black
women are more likely to chemotherapy delays, which further delays surgery (Yung,
2018). Although evidence suggests that structural and systemic racism plays a role in
negative health outcomes from Black women, the present study did not reveal a
statistically significant correlation between breast cancer survival and health care
facilities.
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Interpretation
The purpose of this study was to determine whether poverty, culture, and social
justice affect the breast cancer survival rate of Black and White women in Georgia. To
consider this question, the theoretical concepts of poverty, culture, and social justice were
operationalized using proxy variables that could be measured. Income was used as a
proxy for poverty and operationalized as a categorical variable with four levels based on
the Census Track Poverty Indicator (1 = 0% - < 5% poverty, 2 = 5% - <10% poverty, 3 =
10% - <20% poverty, 4 = 20% - 100% poverty). Race was used as a proxy for culture
and operationalized as a categorical variable with two levels (Black and White). Health
care facility type was used as a proxy for social justice and operationalized as a
categorical variable with three levels (nonprofit, for-profit, and government). Tumor type
and grade was also considered in recognition that health care facilities are not able to
control the health status of patients entering their facility.
Research Question 1
Research Question 1: Is poverty (income) a determinant of the breast cancer
survival rate of Black and White women in Georgia?
H01: Poverty is not a determinant of the breast cancer survival rate of Black
and White women in Georgia.
Ha1: Poverty is a determinant of the breast cancer survival rate of Black and
White women in Georgia.
The results suggested that survival functions among patients with different income
levels were statistically significant. The Census Tract Poverty Indicator in relation to the
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Georgia Cancer Registry indicates the level of poverty in the patient’s area at the time of
diagnosis. A woman with breast cancer in a census tract with 0-<5% poverty (0.8698)
has a slightly higher 5-year survival probability than a woman with breast cancer in a
census tract with 20-100% poverty (0.8020). When levels of poverty were compared
there was a statistically significant difference in the survival function between the lower
percentages of poverty and higher percentages of poverty. The findings suggest that
women with breast cancer in areas of increased poverty will have significantly poorer
health outcomes than woman in areas of low poverty.
These findings confirm Freeman and Chu’s (2005) view that poverty has a
significant impact on incidence, access, and treatment. Lack of health insurance, being
underinsured, poor diet, exposure to toxic environments, and the lack of information and
education related to health influence health seeking behaviors as well as compliance.
These factors can result in delayed treatment of a more advanced stage of breast cancer.
The Freeman and Chu model of social determinants of cancer also suggests that health
care providers may not be as competent or lack board-certification, resulting in failure to
adhere to recommended treatment guidelines.
Research Question 2
Research Question 2: Is culture (race) a determinant of the breast cancer survival
rate of Black and White women in Georgia?
H02: Culture is not a determinant of the breast cancer survival rate of Black
and White women in Georgia.
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Ha2: Culture is a determinant of the breast cancer survival rate of Black and
White women in Georgia.
There was a statistically significant difference in the survival function between
White and Black women with breast cancer. The 5-year survival probability of White
women with breast cancer as 0.8648 and 0.7833 for Black women with breast cancer.
Therefore, race is a significant determinant of breast cancer survival probability.
Although Freeman and Chu (2005) acknowledged that race and culture are not
always synonymous, in health care settings race is often used as both a proxy for culture
and poverty. According to Freeman and Chu, culture can act as a way to interpret
information and respond to diagnosis. Culture can also influence health related behaviors
such as drinking, smoking, and diet.
Research Question 3
Research Question 3: Is social justice (type of health care facility) a determinant
of the breast cancer survival rate of Black and White women in Georgia?
H03: Social justice is not a determinant of the breast cancer survival rate of
Black and White women in Georgia.
Ha3: Social justice is a determinant of the breast cancer survival rate of Black
and White women in Georgia.
There was no statistically significant difference in the survival function of patients
in different health care facilities. Freeman and Chu (2005) viewed social justice in terms
of racism, discrimination, and bias. They recognized that this type of social (in)justice
can influence everything from screening to treatment. The report “Unequal Treatment:
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Confronting Racial and Ethnic Disparities in Health Care” by The Institute of Medicine
showed evidence of racial bias along the spectrum of cancer care. Whether conscious or
implicit, providers were shown to adhere to standards of care (Nelson, 2002).
Research Question 4
Research Question 4: What is the relationship between poverty, culture, and
social justice as a determinant of the breast cancer survival rate of Black and
White women in Georgia?
H04: None of the independent variables (poverty, culture, and social justice)
have a statistically significant relationship on breast cancer survival rates of
Black and White women in Georgia.
Ha4: The independent variables (poverty, culture, and social justice) have a
statistically significant relationship on breast cancer survival rates of Black
and White women in Georgia.
When breast cancer survival was compared to race there was a statistically
significant relationship. The hazard of death for a Black woman with breast cancer was
1,270 times the hazard if White women. However, there was no statistically significant
relationship between breast cancer survival and income or health care facility. There was
a statistically significant relationship between breast cancer and tumor grade.
Specifically, the hazard of death for patients with grade I tumor was 0.4442 times of the
hazard for patients with grade II tumor and the hazard of death for patients with grade I
tumor was 0.3797 times of the hazard for patients with grade III tumor. This may suggest
that Race may more appropriately be a biological proxy than a socio-economic proxy.
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Limitations
The data used to analyze the research questions will be collected from the Georgia
Cancer Registry which collects data for one state and the American Hospital Association.
Therefore, the findings cannot be generalized nationally. Additionally, the quantitative
results of the study can only demonstrate correlation and not causation.
This study was limited to the study of health care facilities in Georgia and to
Black and White women in Georgia diagnosed with breast cancer. The study will
analyzed only data downloaded from Georgia Cancer Registry and the American
Hospital Association. This study sought to determine if there is a correlation between the
stated variables. The study did not determine the causal nature of any identified
relationship. It provided preliminary data that can serve as a foundation for further
research that can elucidate causal relationships.
The study was also limited by the cost of the data. Hospital data is considered
proprietary and therefore is sold to researchers. The limited database I was able to
purchase cost several hundred dollars. The addition of additional variables of interest
such as insurance types accepted, training facility, breast cancer technology available
would have resulted in a database that cost thousands rather than hundreds of dollars.
A further limitation is that Georgia State does not encourage data analysis of
specific hospitals, therefore all analysis was limited to health care facility type. A
supplementary analysis of how the type of breast cancer screening services and
treatments offered could potential influence on survival probability was limited by the
scope of the data provided.
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Recommendations
The findings of the study suggest that health care facility type as defined by
control/ownership type does not influence breast cancer survival rates in the state of
Georgia. However, as discussed in the literature review, previous studies have
demonstrated racial bias by physicians and perceived racial bias by Black patients. Given
the well-documented history of institutionalized racism within the health care system
towards Black patients, the results were unexpected but not surprising considering the
unwillingness of both hospitals and the State of Georgia to permit a resource detailed,
hospital-specific study of racial bias related to breast cancer survival outcomes.
The first recommendation would be to expand the hospital variables to include
factors such as bed size, rural/urban, teaching status, community partnerships, patient
population, cancer services/technology available, payment types, and hospital
demographics. The above variables could provide additional insight into the availability
of services available in different types of communities as well as the training and more
specifically the availability of well-trained physicians.
The second recommendation is to expand the size of the study. This study only
included data for a single state, Georgia, so the results cannot be generalized. Data
should be gathered from the Surveillance, Epidemiology, and End Results database with
a national sample and aligned with the American Hospital Association data on hospitals.
The health disparity of breast cancer survival rates between Black and White women is
nationwide. For results that are meaningful, the sample should be drawn nationally.
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A third recommendation is a mixed methods study as a prospective cohort.
Although a quantitative study can demonstrate correlation, it cannot illustrate causation.
The study was a quantitative study and therefore is limited to correlations of data, a
quantitative study will not explain the why. Quantitative finding coupled with findings
from qualitative interviews of both patients and physicians and reviews of records may
help to guide the understanding of racial disparities in breast cancer survival rates.
Implications
At the core of this study is the question, what is the best option for care for a
woman with breast cancer, particularly Black women with demonstrated higher mortality
rates. This is socially significant because if the survival probability can increase based on
where they are getting care, then there are actions that can be taken that can improve care
for all breast cancer patients. For example, if Black women were to have better outcomes
in government owned and controlled hospitals, further research could determine the best
practices for improved survival for all patients, not just Black women.
A study of this type can also have policy implications. If hospital type influences
breast cancer mortality rate, do we need to examine the way insurance handles referrals.
Should referrals be based on race, tumor, grade and hospital type? Do we use this
information to justify how health insurance is allocated? How resources are allocated.
Conclusion
The study results suggest that there is no relationship between healthcare facility
type and breast cancer survival probability. This result was unexpected given the number
of studies illustrating racial disparities in treatment. This may imply that all hospital
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types perform poorly in the treatment of Black women and therefore the problem is
systemic and needs to be examined using a different method. Another implication may
be that given the disparate mortality rates for Black women there may be a need to
differentiate the treatment protocol to specifically address the health needs of Black
women.
It is interesting to note the even though Black women experience poorer breast
cancer survival rates when compared to their peers, there has not been a corresponding
uptick in breast cancer awareness programs that specifically target Black women. Most
breast cancer awareness programs are noticeably race neutral. The studies have been
conducted demonstrating the health disparity of breast cancer survival rates, the studies
have been conducted demonstrating that Black women are more frequently diagnosed
with triple negative breast cancer, which is the worst type of breast cancer, yet most
breast cancer programs remain race neutral, along with screening recommendations, and
insurance handling of referrals.
Although the results of this study did not suggest that health care facility type
influence breast cancer survival rates, perhaps the failure to demonstrate any correlation
is the most damaging evidence of institution racial bias. Given the plethora of evidencebased information revealing a race-based health disparity, health care facilities should be
doing more to positively influence health outcomes for Black women.
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